Founded by a group of Swiss biologists in 1945, IBSA – Institute Biochemical SA – has gained unique experience in pharmaceutical research and technology.
IBSA has used its experience and expertise in the pharmaceutical field to branch out and develop medical devices for dermatology based on hyaluronic acid – thus giving birth to a dedicated dermoaesthetic brand: IBSA Derma.
IBSA Derma distinguishes itself in this vast market because it controls the entire product life cycle: from the biofermentation production of the raw material to it being ready to use in pre-filled syringes.
IBSA GROUP
IBSA COVERES 9 MAIN THERAPEUTIC AREAS:
IBSA, ONE OF THE MOST IMPORTANT EXPERT AND MANUFACTURER OF HYALURONIC ACID, HAS DEVELOPED AN INTENSIVE R&D PROGRAM CONCERNING THIS MOLECULE FOR THE AESTHETIC MEDICINE.
„IBSA Derma“ products are designed to reduce the effects of physiological processes that lead to a decrease in hyaluronic acid in the skin and to restore skin hydration, elasticity and tone. The aim is that the deep hydration of the skin has a synergistic effect and at the same time lifts the skin.
IBSA Derma offers a range of products with the following brands: Viscoderm®, Profhilo® ir Aliaxin®, pagamintų įgyvendinant Hydrolift® Action koncepciją.
The IBSA has changed the approach to beauty – emphasizing the authenticity of each person.
Hydrolift® Action concept emphasizes the synergistic effect when hyaluronic acid produced according to the patented IBSA technology is selected for use. This acid creates the best conditions to reduce the aging process.
IBSA hyaluronic acid is ultra pure, produced through biofermentation using a natural, non GMO bacterial strain: Streptococcus Zooepidemicus equi – ranked worldwide as top high quality raw material.
